Data Foundry

Medical device recalls 2022

Zio AT Clinical Reference Manual — Class II medical device recall Z-0183-2023

Ongoing recall by iRhythm Technologies, Inc., reported 2022-11-16, distributed in AL, AR, AZ, CA, CO, CT, DC, DE…. Ambulatory ECG monitoring system labeling update: 1) Clinically actionable arrhythmia notifications delayed un

Recall numberZ-0183-2023
Product typeMedical device
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmiRhythm Technologies, Inc., Cypress, CA, United States
Recall initiated2022-09-28
Classified2022-11-04
Reported by FDA2022-11-16
DistributedAL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, VA, VT, WA, WI, WV
Quantity1,443
Reason classeslabeling
UPC / GTIN / UDI-DI00869770000210
Model numbersALB0031, ALB0034

Product

Zio AT Clinical Reference Manual, Part: ALB0031, and Zio AT Important Information Pamphlet, Part: ALB0034. For Zio Ambulatory ECG monitoring system

Reason for recall

Ambulatory ECG monitoring system labeling update: 1) Clinically actionable arrhythmia notifications delayed until patient registration is complete; 2) Patches limited to 100 symptomatic and 500 asymptomatic wireless transmissions; once the maximum transmission limit is reached for either type, any further transmissions for that type will cease. Risk of delayed reporting to health providers.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-0183-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.